Another company has entered the fray in the eternal battle between humans and bacteria. Day Zero Diagnostics Inc. aims to produce whole genome sequencing-based diagnostic technologies that quickly identify the species and antibiotic resistance profile of bacterial pathogens from a blood sample. In a vote of confidence that the company is on the right track, the global non-profit Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) awarded Day Zero another $8.2 million. The latest funding pushes Day Zero’s awards from CARB-X over $16 million. Read More
Deepull Diagnostics SL has raised €13 million (US$12.71 million) in a series B round to advance development of a PCR-based rapid diagnostic for the early diagnosis of sepsis and acute infections. Read More
Endpoint solutions company Clario Inc. has published a roadmap on how artificial intelligence (AI) can be used to improve the experience of patients participating in decentralized clinical trials (DCTs). Read More
The U.K. is launching a coordinated national program of research into the unprecedented outbreak of monkeypox that has spread across Europe and North America – regions where the disease is not endemic – over the past six months. Taking a lead from the SARS-CoV-2 playbook, there will be work to sequence the viral genome and to study how it is evolving, linking this to changes in the transmission and pathology of the virus. Read More
Expanding its mandate to accelerate access to essential medicines to people in low- and middle-income countries, the Medicines Patent Pool signed its first voluntary licensing agreement for a cancer treatment, Novartis AG’s Tasigna (nilotinib). A twice-daily oral drug, Tasigna is a tyrosine kinase inhibitor included on the World Health Organization’s Model List of Essential Medicines as a second-line treatment for adult and pediatric chronic myeloid leukemia. Read More
New hires and promotions in the med-tech industry, including: Biovica International, Hemosonics, Olympus, Predictive Oncology, Vicarious Surgical. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abiomed, Cellibre, Codex DNA, Concept Medical, Perkinelmer, T2 Biosystems, Telesis Bio. Read More
